COO vs VNRX · P/E 36, rev $4.09B vs rev $1.4M
The Cooper Companies, Inc (COO) versus Volitionrx Ltd (VNRX) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Volitionrx Ltd (VNRX) is a medical devices company listed on AMEX.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported VNRX revenue for 2026-06-30 was $1.4M. Net income was -$14.0M. Revenue was up 40.5% from 2026-03-31 to 2026-06-30. VNRX currently screens at market cap $15.9M.
COO currently screens at market cap $14.92B and trailing P/E 36.1. VNRX currently screens at market cap $15.9M.
Not investment advice. Open the COO and VNRX stock pages for the full models.
Not investment advice.